|
Read more ›› |
By: GlobenewsWire - 09 Feb 2023
|
Related companies:
MediciNova, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 09 Feb 2023
|
Related companies:
Regeneron Pharmaceuticals Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 09 Feb 2023
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 09 Feb 2023
|
Related companies:
Abbott Laboratories |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 09 Feb 2023
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 09 Feb 2023
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 09 Feb 2023
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 09 Feb 2023
|
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
PDS Biotechnology Corporation |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
Nurix Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
Bright Minds Biosciences, Inc. |
Bright Minds Biosciences |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
Eledon Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
Hyperfine, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
23andMe, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
Aligos Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
TFF Pharmaceuticals, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
4D Molecular Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
DICE Therapeutics, Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
aTyr Pharma Inc. |
Lifecare AS |
Pharmsynthez |
|
|
Read more ›› |
By: GlobenewsWire - 08 Feb 2023
|
Related companies:
Travere Therapeutics, Inc. |
|
|
|